ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
전 세계 에녹사파린 원료의약품 시장 규모는 2024년 1억 7,130만 달러에서 2031년에는 2억 8,708만 달러에 달할 것으로 예상되며, 2025-2031년 5.38%의 CAGR을 기록할 것으로 예상됩니다.
북미 에녹사파린 원료의약품 시장 규모는 2024년 2,817만 달러에서 2031년에는 4,023만 달러에 달할 것으로 예상되며, 2025-2031년 예측 기간 동안 3.86%의 CAGR을 기록할 것으로 예상됩니다.
유럽의 에녹사파린 원료의약품 시장 규모는 2024년 9,434만 달러에서 2031년에는 1억 5,391만 달러에 달할 것으로 예상되며, 2025년부터 2031년까지 예측 기간 동안 4.68%의 CAGR을 기록할 것으로 예상됩니다.
아시아태평양의 에녹사파린 원료의약품 시장 규모는 2024년 4,034만 달러에서 2031년에는 7,775만 달러에 달할 것으로 예상되며, 2025년부터 2031년까지 예측 기간 동안 7.46%의 CAGR을 기록할 것으로 예상됩니다.
에녹사파린 원료의약품의 주요 세계 제조업체로는 Hepalink, Yantai Dongcheng Pharmaceutical, Changzhou Qianhong Biopharma, Hebei Changshan Biochemical Pharmaceutical, Hubei Enoray Biopharmaceutical (Tianjin Chasesun Pharmaceutical), Chongqing Yino Pharma, Chengdu Baiyu Pharmaceutical, Haike Group, Jiangxi Haoran Bio-Pharma, Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical) 등이 있으며, 2024년에는 세계 상위 5개 업체가 매출액의 약 69.88%를 차지했습니다.
조사 범위
본 보고서는 에녹사파린 원료의약품 세계 시장을 정량적, 정성적 분석의 양면으로 포괄적으로 소개하며, 독자가 비즈니스/성장 전략을 수립하고, 시장 경쟁 상황을 평가하며, 현재 시장에서의 자사 위치를 분석하고, 에녹사파린 원료의약품에 관한 정보에 입각한 비즈니스 의사결정을 에녹사파린 원료의약품에 대한 정보에 입각한 비즈니스 의사결정을 내릴 수 있도록 하는 것을 목적으로 합니다.
이 보고서는 2024년을 기준 연도, 생산량/출하량(Kg) 및 매출액(백만 달러), 2020년에서 2031년까지의 이력 데이터와 예측 데이터로 에녹사파린 원료의약품의 시장 규모와 추정 및 예측을 제공합니다. 이 보고서는 세계 에녹사파린 원료의약품 시장을 포괄적으로 세분화합니다. 제품 유형별, 용도별, 진입 기업별, 지역별 시장 규모도 수록되어 있습니다.
시장을 더 깊이 이해하기 위해 경쟁 상황, 주요 경쟁사 프로필, 각 시장 순위를 게재하고 있습니다. 또한, 기술 동향과 신제품 개발에 대해서도 논의하고 있습니다.
이 보고서는 에녹사파린 원료의약품 제조업체, 신규 진입 기업 및 이 시장의 산업 체인 관련 기업에게 시장 전체 및 기업별, 제품 유형별, 용도별, 지역별 하위 부문의 매출, 생산량, 평균 가격에 대한 정보를 제공합니다.
목차
제1장 에녹사파린 원료의약품 시장 개요
제품 정의
에녹사파린 원료의약품, 항 제Xa인자 활성별
에녹사파린 원료의약품, 용도별
세계 시장 성장 전망
가정과 제한
제2장 제조업체에 의한 시장 경쟁
제3장 에녹사파린 원료의약품 생산, 지역별
세계의 에녹사파린 원료의약품 생산액 예측 : 2020년 대 2024년 대 2031년, 지역별
세계의 에녹사파린 원료의약품 생산액 : 2020-2031년, 지역별
세계의 에녹사파린 원료의약품 생산량 예측 : 2020년 대 2024년 대 2031년, 지역별
세계의 에녹사파린 원료의약품 생산량 : 2020-2031년, 지역별
세계의 에녹사파린 원료의약품 시장 가격 분석 : 2020-2025년, 지역별
세계의 에녹사파린 원료의약품 생산량과 가치, 전년비 성장률
제4장 에녹사파린 원료의약품 소비량, 지역별
세계의 에녹사파린 원료의약품 소비량 예측 : 2020년 대 2024년 대 2031년, 지역별
세계의 에녹사파린 원료의약품 소비량 : 2020-2031년, 지역별
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
제5장 항Xa인자 활성별 부문
세계의 에녹사파린 원료의약품 생산량, 항Xa인자 활성별(2020-2031년)
세계의 에녹사파린 원료의약품 생산액, 항Xa인자 활성별(2020-2031년)
세계의 에녹사파린 원료의약품 가격, 항Xa인자 활성별(2020-2031년)
제6장 용도별 부문
세계의 에녹사파린 원료의약품 생산량, 용도별(2020-2031년)
세계의 에녹사파린 원료의약품 생산액, 용도별(2020-2031년)
세계의 에녹사파린 원료의약품 가격, 용도별(2020-2031년)
제7장 주요 기업 개요
Hepalink
Yantai Dongcheng Pharmaceutical
Changzhou Qianhong Biopharma
Hebei Changshan Biochemical Pharmaceutical
Hubei Enoray Biopharmaceutical(Tianjin Chasesun Pharmaceutical) Enoxaparin API
Global Enoxaparin API market size in terms of revenue is projected to reach 287.08 million USD by 2031 from 171.30 million USD in 2024, with a CAGR 5.38% during 2025-2031.
North America market for Enoxaparin API is estimated to increase from 28.17 million USD in 2024 to reach 40.23 million USD by 2031, at a CAGR of 3.86% during the forecast period of 2025 through 2031.
Europe market for Enoxaparin API is estimated to increase from 94.34 million USD in 2024 to reach 153.91 million USD by 2031, at a CAGR of 4.68% during the forecast period of 2025 through 2031.
Asia-Pacific market for Enoxaparin API is estimated to increase from 40.34 million USD in 2024 to reach 77.75 million USD by 2031, at a CAGR of 7.46% during the forecast period of 2025 through 2031.
The major global manufacturers of Enoxaparin API include Hepalink, Yantai Dongcheng Pharmaceutical, Changzhou Qianhong Biopharma, Hebei Changshan Biochemical Pharmaceutical, Hubei Enoray Biopharmaceutical (Tianjin Chasesun Pharmaceutical), Chongqing Yino Pharma, Chengdu Baiyu Pharmaceutical, Haike Group, Jiangxi Haoran Bio-Pharma, Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical), etc. In 2024, the world's top five vendors accounted for approximately 69.88% of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Enoxaparin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enoxaparin API.
The Enoxaparin API market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Enoxaparin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enoxaparin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Enoxaparin API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Enoxaparin API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Enoxaparin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Table of Contents
1 Enoxaparin API Market Overview
1.1 Product Definition
1.2 Enoxaparin API by Anti-factor Xa Activity
1.2.1 Global Enoxaparin API Market Value Growth Rate Analysis by Anti-factor Xa Activity: 2024 VS 2031
1.2.2 Above 100 IU/mg
1.2.3 Below 100 IU/mg
1.3 Enoxaparin API by Application
1.3.1 Global Enoxaparin API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 0.2ml:2000IU
1.3.3 0.4ml:4000IU
1.3.4 0.6ml:6000IU
1.3.5 0.8ml:8000IU
1.3.6 1ml:10000IU
1.3.7 Others
1.4 Global Market Growth Prospects
1.4.1 Global Enoxaparin API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Enoxaparin API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Enoxaparin API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Enoxaparin API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Enoxaparin API Production Market Share by Manufacturers (2020-2025)
2.2 Global Enoxaparin API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Enoxaparin API, Industry Ranking, 2023 VS 2024
2.4 Global Enoxaparin API Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Enoxaparin API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Enoxaparin API, Manufacturing Sites & Headquarters
2.7 Global Key Manufacturers of Enoxaparin API, Product Type & Application
2.8 Global Key Manufacturers of Enoxaparin API, Date of Enter into This Industry
2.9 Global Enoxaparin API Market Competitive Situation and Trends
2.9.1 Global Enoxaparin API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Enoxaparin API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Enoxaparin API Production by Region
3.1 Global Enoxaparin API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Enoxaparin API Production Value by Region (2020-2031)
3.2.1 Global Enoxaparin API Production Value Market Share by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Enoxaparin API by Region (2026-2031)
3.3 Global Enoxaparin API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Enoxaparin API Production by Region (2020-2031)
3.4.1 Global Enoxaparin API Production Market Share by Region (2020-2025)
3.4.2 Global Forecasted Production of Enoxaparin API by Region (2026-2031)
3.5 Global Enoxaparin API Market Price Analysis by Region (2020-2025)
3.6 Global Enoxaparin API Production and Value, Year-over-Year Growth
3.6.1 North America Enoxaparin API Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Enoxaparin API Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Enoxaparin API Production Value Estimates and Forecasts (2020-2031)
3.6.4 India Enoxaparin API Production Value Estimates and Forecasts (2020-2031)
4 Enoxaparin API Consumption by Region
4.1 Global Enoxaparin API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Enoxaparin API Consumption by Region (2020-2031)
4.2.1 Global Enoxaparin API Consumption by Region (2020-2031)
4.2.2 Global Enoxaparin API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Enoxaparin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Enoxaparin API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Enoxaparin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Enoxaparin API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Spain
4.5 Asia Pacific
4.5.1 Asia Pacific Enoxaparin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Enoxaparin API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 Southeast Asia
4.5.7 India
4.5.8 Australia
4.6 Latin America
4.6.1 Latin America Enoxaparin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America Enoxaparin API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.7 Middle East and Africa
5 Segment by Anti-factor Xa Activity
5.1 Global Enoxaparin API Production by Anti-factor Xa Activity (2020-2031)
5.1.1 Global Enoxaparin API Production by Anti-factor Xa Activity (2020-2025)
5.1.2 Global Enoxaparin API Production by Anti-factor Xa Activity (2026-2031)
5.1.3 Global Enoxaparin API Production Market Share by Anti-factor Xa Activity (2020-2031)
5.2 Global Enoxaparin API Production Value by Anti-factor Xa Activity (2020-2031)
5.2.1 Global Enoxaparin API Production Value by Anti-factor Xa Activity (2020-2025)
5.2.2 Global Enoxaparin API Production Value by Anti-factor Xa Activity (2026-2031)
5.2.3 Global Enoxaparin API Production Value Market Share by Anti-factor Xa Activity (2020-2031)
5.3 Global Enoxaparin API Price by Anti-factor Xa Activity (2020-2031)
6 Segment by Application
6.1 Global Enoxaparin API Production by Application (2020-2031)
6.1.1 Global Enoxaparin API Production by Application (2020-2025)
6.1.2 Global Enoxaparin API Production by Application (2026-2031)
6.1.3 Global Enoxaparin API Production Market Share by Application (2020-2031)
6.2 Global Enoxaparin API Production Value by Application (2020-2031)
6.2.1 Global Enoxaparin API Production Value by Application (2020-2025)
6.2.2 Global Enoxaparin API Production Value by Application (2026-2031)
6.2.3 Global Enoxaparin API Production Value Market Share by Application (2020-2031)
6.3 Global Enoxaparin API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Hepalink
7.1.1 Hepalink Enoxaparin API Company Information
7.1.2 Hepalink Enoxaparin API Product Portfolio
7.1.3 Hepalink Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Hepalink Main Business and Markets Served
7.1.5 Hepalink Recent Developments/Updates
7.2 Yantai Dongcheng Pharmaceutical
7.2.1 Yantai Dongcheng Pharmaceutical Enoxaparin API Company Information
7.2.2 Yantai Dongcheng Pharmaceutical Enoxaparin API Product Portfolio
7.2.3 Yantai Dongcheng Pharmaceutical Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Yantai Dongcheng Pharmaceutical Main Business and Markets Served
